Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson’s disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004)-Reference-Cited by-同舟云学术

Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson’s disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004)

Published:2022-05 Issue: Volume:61 Page:102765
ISSN:1873-5061
Container-title:Stem Cell Research
language:en
Short-container-title:Stem Cell Research

Author:

Novak Gabriela,Finkbeiner Steven,Skibinski Gaia,Bernini Michela,Donato Cristina,Skupin Alexander

Funder

Michael J. Fox Foundation for Parkinson's Research

Gladstone Institutes

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference5 articles.

1. The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity;Ando;Mol. Neurodegeneration,2017

2. Interaction between Parkin and α-synuclein in PARK2-mediated Parkinson’s disease;Madsen;Cells,2021

3. Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006);Novak;Stem Cell Res.,2021

4. Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson’s disease;Novak;Commun. Biol.,2022

5. Parkinson’s disease-linked Parkin mutations impair glutamatergic signaling in hippocampal neurons;Zhu;BMC Biol.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Protease-Activated Receptor-2 Activation in Parkinson’s Disease Using 1-Piperidin Propionic Acid;Biomedicines;2024-07-22

2. Cell reprogramming in a predictable manner on the superhydrophobic microwell array chip;Biomaterials;2023-10

3. Increased cysteine metabolism in PINK1 models of Parkinson's disease;Disease Models & Mechanisms;2023-01-01